Evaluation of adiponectin and calcium levels in patient's type II diabetics with obesity in Salah El-Din Province

Main Article Content

Saleh Attallah Burjes Aljuboury
Nadia Ahmed Saleh Aljuboury

Abstract

The association between obesity and type 2 diabetes may be partially mediated by altered adipose tissue secretion of adipokines. Adiponectin is an adipokines with anti-inflammatory and insulin-sensitive properties. It is a regulated low secretion in obesity, the concentrations of adiponectin and calcium in the blood serum of obese patients and type 2 diabetes will be estimated in Salah al-Din Province: Iraq, where the study included (90) samples (60) for patients with diabetes - type II and (30) from healthy subjects. The ages of the affected and healthy people ranged between 35-75 years. The results showed a significant increase at the level of probability (P≤0.01) in the level of adiponectin and calcium concentrations in patients with type 2 diabetes compared to healthy subjects, and through the results we obtained, adiponectin may play an important role in prevention of type 2 diabetes

Article Details

How to Cite
Saleh Attallah Burjes Aljuboury, & Nadia Ahmed Saleh Aljuboury. (2022). Evaluation of adiponectin and calcium levels in patient’s type II diabetics with obesity in Salah El-Din Province. Tikrit Journal of Pure Science, 27(5), 12–15. https://doi.org/10.25130/tjps.v27i5.8
Section
Articles

References

[1] Engelgau, Michael M. "Diabetes diagnostic criteria and impaired glycemic states: evolving evidence base." Clinical Diabetes 22.2 (2004): 69-70.

[2] Votey, S. peters A., Lober w. and Brenner B "Diabetes Mellitus , type -AReview", Emedicine. Secton (2002):1-11.

[3] Komindr, Surat. "Phytate and fiber content in Thai fruits commonly consumed by diabetic patients." J Med Assoc Thai 87.12 (2004): 1444-6.

[4] Kadowaki, T. ; Yamauchi, T. ; Kubota, N.; Hara, K.; Ueki, K. and Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. , 116 (2017): 1784-92.

[5] Rabe, K.; Lehrke, M.; Parhofer, K.G. and Broedl, U.C. Adipokines and insulin resistance.Mol Med. 14 (11-12)(2015) : 741-51.

[6] Hajer, G.R.; van Haeften, T.W. and Visseren, F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. , 29 (24)(2016) : 2959-71.

[7] Bruun, J.M.; Lihn, A.S.; Verdich, C. et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J PhysiolEndocrinolMetab.285 (3)(2019): E527- E533.

[8] Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, Sempos CT, Picciano MF. Estimation of total usual calcium and vitamin D intake in the United States. Journal of Nutrition. 140(4)(2017):817–22.

[9] John W Baynes. Marek H Dominiczak, Medical biochemistry. second edition (2012):p245-259.

[10] Uzogara, Stella G. "Obesity epidemic, medical and quality of life consequences: a review." International Journal of Public Health Research 5.1 (2017): 1.

[11] Tietz, N.W. Clinical Guide to laboratory tests. 3rd ed. W.B. Saunders, Philadephia. (2014) pp. 578-580.

[12] Ray Sarker B. C.et al, Anal. Biochem. (2011):20,155.

[13] Lyon CJ; Law RE. and Hsueh WA. Minireview: Adiposity, inflammation and atherosclerosis. Endocrinology 144(2009): 2195-2200.

[14] Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological chemistry, 270(45)(2018), 26746-26749.

[15] Wasan A A; Mohammed A.; Sundus Kh. Estimation of serum calcium and parathyroid hormone (PTH) levels in diabetic patients in correlation with age and duration of disease. Iraqi J. Comm. Med., Apr. (2012) ,2.

[16] Zatterale, Federica, et al. "Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes." Frontiers in physiology 10 (2020): 1607.